FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243361884> ?p ?o ?g. }

• W4243361884 abstract "<sec> <title>BACKGROUND</title> More than 3.1 million men in the United States are prostate cancer survivors. These men may improve their physical function, quality of life, and potentially their prognosis by adopting healthier lifestyle habits. The internet provides a scalable mechanism to deliver advice and support about improving physical activity and dietary habits, but the feasibility and acceptability of a Web-based lifestyle intervention and the dose of support necessary to improve health behaviors are not yet known. </sec> <sec> <title>OBJECTIVES</title> The Community of Wellness is a Web-based intervention focused on supporting exercise and healthy dietary practices for men with prostate cancer. The objectives of this study were to determine the feasibility, acceptability, and preliminary efficacy of the Community of Wellness Web portal among prostate cancer survivors by conducting a randomized controlled trial (RCT) comparing 4 levels of additive Web-based content and interaction with participants: Level 1 (Teaching; Control), Level 2 (Teaching + Tailoring), Level 3 (Teaching + Tailoring + Technology), and Level 4 (Teaching + Tailoring + Technology + Touch). </sec> <sec> <title>METHODS</title> This is a single-blinded RCT comparing 3 levels of behavioral support within the Community of Wellness Web portal intervention (Levels 2 to 4) with each other and with the control condition (Level 1). The control condition receives general static Web-based educational information only on physical activity and dietary habits, self-efficacy for behavior change, motivation for physical activity, and changes in anxiety and treatment-related side effects. We will enroll and randomize 200 men with prostate cancer equally to 4 levels of the Community of Wellness Web-based intervention for 3 months (50 men per level). Surveys will be completed by self-report at baseline, 3 months (immediately postintervention), and 6 months (3 months postintervention). Feasibility and acceptability will be assessed by enrollment statistics, Web-based usage metrics, and surveys at the 3-month time point. We will also conduct focus groups after the postintervention follow-up assessment in a sample of enrolled participants to evaluate elements of usability and acceptability that cannot be obtained via surveys. </sec> <sec> <title>RESULTS</title> Enrollment is ongoing, with 124 enrolled. Study completion (6-month follow-up) is expected by July 2019. </sec> <sec> <title>CONCLUSIONS</title> The goal of the study is to identify the level of support that is feasible, acceptable, promotes behavior change, and improves health in men with prostate cancer to inform future efforts to scale the program for broader reach. </sec> <sec> <title>CLINICALTRIAL</title> ClinicalTrials.gov NCT03406013; https://clinicaltrials.gov/ct2/show/NCT03406013 (Archived by WebCite at http://www.webcitation.org/73YpDIoTX). </sec> <sec> <title>INTERNATIONAL REGISTERED REPOR</title> PRR1-10.2196/11257 </sec>" @default.
• W4243361884 created "2022-05-12" @default.
• W4243361884 creator A5010114692 @default.
• W4243361884 creator A5012580173 @default.
• W4243361884 creator A5014728047 @default.
• W4243361884 creator A5014733479 @default.
• W4243361884 creator A5023602504 @default.
• W4243361884 creator A5034203416 @default.
• W4243361884 creator A5037076014 @default.
• W4243361884 creator A5044287083 @default.
• W4243361884 creator A5048477205 @default.
• W4243361884 creator A5054633971 @default.
• W4243361884 creator A5056296628 @default.
• W4243361884 creator A5056969058 @default.
• W4243361884 creator A5060847909 @default.
• W4243361884 creator A5076701726 @default.
• W4243361884 creator A5080001095 @default.
• W4243361884 creator A5087427252 @default.
• W4243361884 date "2018-06-07" @default.
• W4243361884 modified "2023-09-27" @default.
• W4243361884 title "Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial (Preprint)" @default.
• W4243361884 cites W1524643360 @default.
• W4243361884 cites W1916166078 @default.
• W4243361884 cites W1979266382 @default.
• W4243361884 cites W1984991116 @default.
• W4243361884 cites W1988417475 @default.
• W4243361884 cites W1989629543 @default.
• W4243361884 cites W1992184853 @default.
• W4243361884 cites W2018702836 @default.
• W4243361884 cites W2023645024 @default.
• W4243361884 cites W2024824220 @default.
• W4243361884 cites W2025298047 @default.
• W4243361884 cites W2088443643 @default.
• W4243361884 cites W2100065485 @default.
• W4243361884 cites W2102468400 @default.
• W4243361884 cites W2105626129 @default.
• W4243361884 cites W2111119091 @default.
• W4243361884 cites W2112189062 @default.
• W4243361884 cites W2113051457 @default.
• W4243361884 cites W2119913741 @default.
• W4243361884 cites W2121203305 @default.
• W4243361884 cites W2125931430 @default.
• W4243361884 cites W2136160663 @default.
• W4243361884 cites W2142828526 @default.
• W4243361884 cites W2147312821 @default.
• W4243361884 cites W2157497047 @default.
• W4243361884 cites W2160769891 @default.
• W4243361884 cites W2161431826 @default.
• W4243361884 cites W2161535391 @default.
• W4243361884 cites W2162439599 @default.
• W4243361884 cites W2214671793 @default.
• W4243361884 cites W2224015183 @default.
• W4243361884 cites W2287049434 @default.
• W4243361884 cites W2332940476 @default.
• W4243361884 cites W2419105258 @default.
• W4243361884 cites W2517427649 @default.
• W4243361884 cites W2736136695 @default.
• W4243361884 cites W2744364813 @default.
• W4243361884 cites W2918812541 @default.
• W4243361884 cites W603547002 @default.
• W4243361884 doi "https://doi.org/10.2196/preprints.11257" @default.
• W4243361884 hasPublicationYear "2018" @default.
• W4243361884 type Work @default.
• W4243361884 citedByCount "0" @default.
• W4243361884 crossrefType "posted-content" @default.
• W4243361884 hasAuthorship W4243361884A5010114692 @default.
• W4243361884 hasAuthorship W4243361884A5012580173 @default.
• W4243361884 hasAuthorship W4243361884A5014728047 @default.
• W4243361884 hasAuthorship W4243361884A5014733479 @default.
• W4243361884 hasAuthorship W4243361884A5023602504 @default.
• W4243361884 hasAuthorship W4243361884A5034203416 @default.
• W4243361884 hasAuthorship W4243361884A5037076014 @default.
• W4243361884 hasAuthorship W4243361884A5044287083 @default.
• W4243361884 hasAuthorship W4243361884A5048477205 @default.
• W4243361884 hasAuthorship W4243361884A5054633971 @default.
• W4243361884 hasAuthorship W4243361884A5056296628 @default.
• W4243361884 hasAuthorship W4243361884A5056969058 @default.
• W4243361884 hasAuthorship W4243361884A5060847909 @default.
• W4243361884 hasAuthorship W4243361884A5076701726 @default.
• W4243361884 hasAuthorship W4243361884A5080001095 @default.
• W4243361884 hasAuthorship W4243361884A5087427252 @default.
• W4243361884 hasBestOaLocation W42433618842 @default.
• W4243361884 hasConcept C118552586 @default.
• W4243361884 hasConcept C121608353 @default.
• W4243361884 hasConcept C126322002 @default.
• W4243361884 hasConcept C159110408 @default.
• W4243361884 hasConcept C168563851 @default.
• W4243361884 hasConcept C1862650 @default.
• W4243361884 hasConcept C2779951463 @default.
• W4243361884 hasConcept C2780192828 @default.
• W4243361884 hasConcept C2780665704 @default.
• W4243361884 hasConcept C558461103 @default.
• W4243361884 hasConcept C71924100 @default.
• W4243361884 hasConcept C74909509 @default.
• W4243361884 hasConceptScore W4243361884C118552586 @default.
• W4243361884 hasConceptScore W4243361884C121608353 @default.
• W4243361884 hasConceptScore W4243361884C126322002 @default.
• W4243361884 hasConceptScore W4243361884C159110408 @default.
• W4243361884 hasConceptScore W4243361884C168563851 @default.
• W4243361884 hasConceptScore W4243361884C1862650 @default.

• next